bisantrene has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donehower, M; Gerad, H; Pocelinko, R; Van Echo, DA; Wiernik, PH | 1 |
| Coltman, CA; Cowan, J; Dahlberg, S; Gumbart, CH; Hussein, K; Mills, GM; Neilan, BA | 1 |
2 other study(ies) available for bisantrene and Acute Disease
| Article | Year |
|---|---|
Phase I-II trial of anthracenedicarboxaldehyde in patients with refractory adult acute leukemia.
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Anthracenes; Digestive System; Drug Evaluation; Female; Heart Failure; Humans; Hypotension; Leukemia; Leukemia, Lymphoid; Liver; Male; Middle Aged | 1984 |
Phase II evaluation of bisantrene in acute leukemia. A Southwest Oncology Group Study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia; Male; Middle Aged; Remission Induction | 1989 |